Neuropsychopharmacology
- Comparative rhythmic transcriptome profiling of human and mouse striatal subregions3 years ago
- Correction: Psychosocial moderators of polygenic risk scores of inflammatory biomarkers in relation to GrimAge3 years ago
- GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents3 years ago
- Acetylcholine muscarinic M1 receptors in the rodent prefrontal cortex modulate cognitive abilities to establish social hierarchy3 years ago
- Social odor choice buffers drug craving3 years ago
- Combined treatment with naloxone and the alpha2 adrenoceptor antagonist atipamezole reversed brain hypoxia induced by a fentanyl-xylazine mixture in a rat model3 years ago
- TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent manner3 years ago
Journal of Psychopharmacology
- First study of safety and tolerability of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in patients with alcohol use disorder5 years ago
- Cannabis based medicines and cannabis dependence: A critical review of issues and evidence5 years ago
- Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials5 years ago
- Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer’s disease: Machine learning approaches5 years ago
- Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment5 years ago
- Point-of-care measurement of clozapine concentration using a finger-stick blood sample5 years ago
- Pharmacological evidence of a cholinergic contribution to elevated impulsivity and risky decision-making caused by adding win-paired cues to a rat gambling task5 years ago
European Neuropsychopharmacology
- Offspring studies: Predicting conversion to psychosis5 years ago
- Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions5 years ago
- Rating, berating or overrating antidepressant efficacy? The case of the Hamilton depression rating scale5 years ago
- Suicide in the COVID-19 pandemic: what we learnt and great expectations5 years ago
- Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility5 years ago
- Autoimmune encephalitis or autoimmune psychosis?5 years ago
- Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects5 years ago